Hair Loss Was Reported Far More Often by Women in Zepbound Trials but New Genetics Covers Only Men

Zepbound’s FDA label reports hair loss in 7.1% of women versus 0.5% of men. The newest GLP-1 genetic study looked only at men.

Have A Referral?